The Vegas mpox case: what the CDC said, what it means, and when to get swabbed
Everything I said in today's video, where each claim came from, and the one thing to do with it: a new rash with a fever this fall gets swabbed, not waited out. The short version: Las Vegas just confirmed its first case of the more severe mpox strain in a resident who never traveled, and the CDC's own read is that this strain is now spreading inside the United States on its own.
The Vegas case
“Vegas just reported its first case of the severe mpox strain. The patient never left Las Vegas, and that's the part that matters.”
On October 20, 2026 the Southern Nevada Health District confirmed the first clade I mpox case in a Clark County resident. The person had no reported travel exposure. The district also noted 11 cases of the ordinary clade II strain since August, an uptick, and its health officer said mpox "continues to circulate in our community." Vaccine is available at the district's immunization clinics.
FOX5 Las Vegas, October 20, 2026Las Vegas Review-Journal, October 20, 2026Southern Nevada Health District newsroom
The CDC's words
“The CDC calls it likely sustained transmission.”
From the CDC's current situation summary, reviewed October 14, 2026: "Since August 2026, an increasing proportion of clade I cases in the United States have been reported in individuals with no recent international travel or known links to people who had recently traveled. Cases with presumed domestic transmission have been reported in more than 10 jurisdictions, indicating a likely transition to sustained clade Ib transmission in the United States." And: "CDC expects to see additional cases of both travel-related and domestically acquired cases of clade Ib occurring across the United States." The same page counts more than 90 laboratory-confirmed clade I cases in at least 23 states plus Puerto Rico since November 2024.
CDC, Global Mpox: Current Situation (reviewed October 14, 2026)CDC, U.S. case data
You remember mpox
“Summer of 2022, the rash that went through thirty thousand Americans in a few months. That was the mild strain. This is the other one.”
The 2022 outbreak was clade II. Through November 30, 2024 the United States had recorded 34,349 cases and 63 deaths from it. Clade I is the strain that has historically caused more severe disease; the CDC's own risk assessment puts it this way: "In previous outbreaks, clade I has caused a higher number of persons to have severe disease than clade II within close-contact settings, typically in a household." One honest caveat the video did not have room for: the current clade Ib outbreak in Africa has a case fatality rate estimated under half a percent, and the numbers in the United States are too small to say how it will behave here. "Severe" is the historical record, not a prediction about you.
PAHO/WHO situation report, December 2024 (U.S. totals)CDC risk assessment: clade I mpoxCIDRAP on the two clades
How it got here
“At first, this strain only came in on airplanes. But since August, more and more cases have no trip and no traveler behind them.”
The first U.S. clade I case was diagnosed in California in November 2024 in a traveler. Through 2025 the cases were almost all travel-linked, with one small locally acquired cluster in Southern California in October 2025. The CDC's August 2026 surveillance report counted 10 clade Ib cases in 2025, six of them tied to travel from an affected country, and "no clade Ib deaths were reported." The shift the CDC describes began in August 2026, when a rising share of new cases had no travel and no traveler behind them.
CDC MMWR, August 20, 2026: Monkeypox virus surveillance, United States, 2024 to 2025CDC situation summary
What it has done so far
“Nobody in this country has died of it, and most people are low risk. But in California, the first three people who caught it locally all ended up in the hospital. One in the ICU. None of them were vaccinated.”
Both halves are true at once. The CDC: "there have been no deaths associated with these cases and most people had relatively mild illness," and "the risk posed by the clade I monkeypox outbreak to most people within the United States remains low." The California report, published in NEJM Evidence in December 2025: the three men who caught it locally in Southern California "were hospitalized (including one in the intensive care unit) with mpox-associated conditions, including secondary skin or soft-tissue bacterial infections and airway compromise... None were previously vaccinated... All patients recovered with supportive care." For comparison, the same report notes that about 5 percent of unvaccinated people with the ordinary clade II strain in California were hospitalized.
Tang and colleagues, NEJM Evidence, December 17, 2025Same report, free PDF via CIDRAPCalifornia Department of Public Health, October 17, 2025
What to do
“A new rash with a fever is not a wait-and-see. Get it swabbed. The test is a Q-tip on the spot, and it's the only way to know which strain you've got.”
This is the part of the page to keep.
- What it looks like. A rash that can start as flat spots and become firm bumps, blisters, then scabs, often on the face, hands, genitals or around the anus, sometimes only one or two spots. Fever, swollen lymph nodes, headache and muscle aches can come before the rash or with it. Symptoms usually start 3 to 17 days after exposure.
- How it spreads. Close, personal, usually skin-to-skin contact, including sex, and through shared bedding, towels or clothing that touched the rash. It is not spreading through the air of a casino floor. Being in Las Vegas is not an exposure.
- Get it swabbed, this week. The test is a PCR on a swab of the rash itself. Call ahead so the clinic can plan, and ask them to send the swab for mpox. Clade-specific testing exists; the lab can tell which strain it is.
- Until you know, cover the rash, keep your own towel and bedding, and stay away from close contact with others.
- If you are in a higher-risk group, there is a two-dose vaccine, and one dose from 2022 is not a complete series. Your local health department can tell you where to get it.
CDC: signs and symptomsCDC: diagnosis and testing (the lesion swab)CDC: prevention
What this is not
“Most people are low risk.”
- It is not a reason to cancel a trip. The risk comes from close contact with someone who has it, not from a city.
- It is not COVID. No airborne spread across a room. The 2022 outbreak was contained by testing, isolation and vaccination of the people at risk, and that is the same playbook here.
- It is not a verdict on anyone. Most U.S. cases have been among gay and bisexual men and their social networks, which is who the targeted vaccine offers are for. Anyone with the rash can catch it and spread it, which is why the swab is the rule for everyone.
For clinicians
- Collect two swabs per lesion from two or three lesions so clade-specific PCR can be run; commercial labs and public health labs both test. Non-variola orthopoxvirus positive with clade II negative should trigger a call to the health department for clade I confirmation.
- The California cluster (NEJM Evidence, Dec 2025): three unvaccinated men, 25 to 40, no travel, all hospitalized, one ICU, secondary bacterial skin infections and airway compromise; none received tecovirimat; all recovered. The authors' comparison: about 5 percent of unvaccinated clade IIb cases in California were hospitalized over the same period.
- Clade I cases and contacts are reportable; CDC's clinical guidance for clade I and the current counts are on the situation summary. Vaccine (MVA-BN, two doses 28 days apart) is presumed effective against clade Ib; one dose is not a series.
CDC diagnosis and testingTang 2025MMWR surveillance 2024 to 2025
Not medical advice for your situation. Nobody paid for this page. If you have a new rash with a fever, call a clinic today and ask for the swab.
Know someone this is for? Send them this page.
Every number on this page links to where it came from. If I got one wrong, tell me and I'll correct it here.